Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Zhongping Duan, Hong Tang et al.|Hepatology International|2018Cited by 22
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single‐arm, open‐label, phase 3 trialYanhang Gao, Fei Kong, Guangming Li et al.|Liver International|2020Cited by 22